Literature DB >> 7739505

The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis.

T Owens1, S Sriram.   

Abstract

Two questions were posed at the beginning of this article. Is EAE a good model for MS? And, is MS an autoimmune disease? The first question is easier to address than the second. EAE is the best available model for the inflammatory processes that occur in MS, and for the disease process. The latter depends somewhat on study of chronic relapsing EAE, rather than early or mono-episodic EAE, which, although of great immunological interest, is of less relevance to the established disease that presents as MS. The second question asks whether MS fulfills Koch's postulates as an autoimmune disease. MS has all the hallmarks of an inflammatory disease of the CNS. The question then is whether the inflammation is autoimmune. The evidence presented shows a considerable autoimmune component to MS inflammation, raising the subsidiary question of whether autoimmune reactivity induces MS. This remains unanswerable for the present, and it should be kept in mind that the same question also would be unanswerable by observation of EAE. The major postulate therefore remains unfulfilled. Diagnosis of MS as an autoimmune disease requires definitive identification of the autoantigen; otherwise, the possibility remains open that this is a disease resulting from the inadvertent activation and dysregulation of immune processes in the CNS that, themselves, are not directed at that organ.

Entities:  

Mesh:

Year:  1995        PMID: 7739505

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  13 in total

1.  Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells.

Authors:  M J Carson; C R Reilly; J G Sutcliffe; D Lo
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 2.  Immunotherapy of inflammatory demyelinating diseases of the central nervous system.

Authors:  J J Bright; S Sriram
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration.

Authors:  S Schilling; S Goelz; R Linker; F Luehder; R Gold
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 4.  The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications.

Authors:  William A Sheremata; Alireza Minagar; J Steven Alexander; Timothy Vollmer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte.

Authors:  Gladson Muthian; John J Bright
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

6.  Differential influence of interleukin-12 in the pathogenesis of autoimmune and virus-induced central nervous system demyelination.

Authors:  J J Bright; M Rodriguez; S Sriram
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 7.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01

8.  A regenerative approach to the treatment of multiple sclerosis.

Authors:  Brian R Lawson; Peter G Schultz; Luke L Lairson; Vishal A Deshmukh; Virginie Tardif; Costas A Lyssiotis; Chelsea C Green; Bilal Kerman; Hyung Joon Kim; Krishnan Padmanabhan; Jonathan G Swoboda; Insha Ahmad; Toru Kondo; Fred H Gage; Argyrios N Theofilopoulos
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

9.  Central nervous system demyelination associated with etanercept in a 51 years old woman.

Authors:  Wanis H Ibrahim; Mohammed Hammoudah; Naveed Akhtar; Hassan Al-Hail; Dirk Deleu
Journal:  Libyan J Med       Date:  2007-06-01       Impact factor: 1.657

10.  Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation.

Authors:  Gisa Ellrichmann; Jan Thöne; De-Hyung Lee; Rudolph A Rupec; Ralf Gold; Ralf A Linker
Journal:  J Neuroinflammation       Date:  2012-01-20       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.